Llwytho...
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
There is a global obesity epidemic that will continue to be a financial burden on healthcare systems around the world. Tackling obesity through diet and exercise should always be the first intervention, but this has not proved to be effective for a large number of patients. Pharmacotherapeutic optio...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Adv Chronic Dis |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772342/ https://ncbi.nlm.nih.gov/pubmed/26977279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315620180 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|